메뉴 건너뛰기




Volumn 28, Issue 10, 2007, Pages 2009-2015

MIF-1 and its peptidomimetic analogs attenuate haloperidol-induced vacuous chewing movements and modulate apomorphine-induced rotational behavior in 6-hydroxydopamine-lesioned rats

Author keywords

6 Hydroxydopamine; Dopamine; Melanocyte stimulating hormone release inhibiting factor 1 (MIF 1); Parkinson's disease; Tardive dyskinesia; Vacuous chewing movements

Indexed keywords

APOMORPHINE; HALOPERIDOL; OXIDOPAMINE; PROLYLLEUCYLGLYCINAMIDE;

EID: 34548699670     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2007.07.026     Document Type: Article
Times cited : (9)

References (52)
  • 2
    • 0016685516 scopus 로고
    • Potentiation of levodopa effect by intravenous l-prolyl-l-leucyl-glycine amide in man
    • Barbeau A. Potentiation of levodopa effect by intravenous l-prolyl-l-leucyl-glycine amide in man. Lancet 2 (1975) 683-684
    • (1975) Lancet , vol.2 , pp. 683-684
    • Barbeau, A.1
  • 3
    • 0018213664 scopus 로고
    • Peptides in Parkinson's disease
    • Barbeau A. Peptides in Parkinson's disease. Adv Exp Med Biol 113 (1978) 101-110
    • (1978) Adv Exp Med Biol , vol.113 , pp. 101-110
    • Barbeau, A.1
  • 4
    • 0021040859 scopus 로고
    • 3H]apomorphine binding sites
    • 3H]apomorphine binding sites. Gen Pharmacol 14 (1983) 609-614
    • (1983) Gen Pharmacol , vol.14 , pp. 609-614
    • Bhargava, H.N.1
  • 6
    • 0021799812 scopus 로고
    • Active and inactive l-prolyl-l-leucyl glycinamide synthetic analogs in rat models of levodopa-treated Parkinson's disease
    • Case T.C., Snider S.R., Hruby V.J., and Rockway T. Active and inactive l-prolyl-l-leucyl glycinamide synthetic analogs in rat models of levodopa-treated Parkinson's disease. Life Sci 36 (1985) 2531-2537
    • (1985) Life Sci , vol.36 , pp. 2531-2537
    • Case, T.C.1    Snider, S.R.2    Hruby, V.J.3    Rockway, T.4
  • 8
    • 0019798052 scopus 로고
    • Effect of l-prolyl-l-leucyl-glycinamide (PLG) on neuroleptic-induced catalepsy and dopamine/neuroleptic receptor bindings
    • Chiu S., Paulose C.S., and Mishra R.K. Effect of l-prolyl-l-leucyl-glycinamide (PLG) on neuroleptic-induced catalepsy and dopamine/neuroleptic receptor bindings. Peptides 2 (1981) 105-111
    • (1981) Peptides , vol.2 , pp. 105-111
    • Chiu, S.1    Paulose, C.S.2    Mishra, R.K.3
  • 9
    • 0021024260 scopus 로고
    • Are the pharmacological effects of l-prolyl-l-leucyl-glycinamide (PLG) mediated through specific receptor mechanisms?
    • Chiu S., Wong Y.W., Wan Y.P., Chiu P., and Mishra R.K. Are the pharmacological effects of l-prolyl-l-leucyl-glycinamide (PLG) mediated through specific receptor mechanisms?. Prog Neuropsychopharmacol Biol Psychiatry 7 (1983) 739-742
    • (1983) Prog Neuropsychopharmacol Biol Psychiatry , vol.7 , pp. 739-742
    • Chiu, S.1    Wong, Y.W.2    Wan, Y.P.3    Chiu, P.4    Mishra, R.K.5
  • 10
    • 0036490942 scopus 로고    scopus 로고
    • Allosteric binding sites on cell-surface receptors: novel targets for drug discovery
    • Christopoulos A. Allosteric binding sites on cell-surface receptors: novel targets for drug discovery. Nat Rev Drug Discov 1 (2002) 198-210
    • (2002) Nat Rev Drug Discov , vol.1 , pp. 198-210
    • Christopoulos, A.1
  • 11
    • 0036258990 scopus 로고    scopus 로고
    • G protein-coupled receptor allosterism and complexing
    • Christopoulos A., and Kenakin T. G protein-coupled receptor allosterism and complexing. Pharmacol Rev 54 (2002) 323-374
    • (2002) Pharmacol Rev , vol.54 , pp. 323-374
    • Christopoulos, A.1    Kenakin, T.2
  • 12
    • 0014208039 scopus 로고
    • Aromatic amino acids and modification of parkinsonism
    • Cotzias G.C., Van Woert M.H., and Schiffer L.M. Aromatic amino acids and modification of parkinsonism. N Engl J Med 276 (1967) 374-379
    • (1967) N Engl J Med , vol.276 , pp. 374-379
    • Cotzias, G.C.1    Van Woert, M.H.2    Schiffer, L.M.3
  • 13
    • 0036283426 scopus 로고    scopus 로고
    • Modeling Parkinson's disease in rats: an evaluation of 6-OHDA lesions of the nigrostriatal pathway
    • Deumens R., Blokland A., and Prickaerts J. Modeling Parkinson's disease in rats: an evaluation of 6-OHDA lesions of the nigrostriatal pathway. Exp Neurol 175 (2002) 303-317
    • (2002) Exp Neurol , vol.175 , pp. 303-317
    • Deumens, R.1    Blokland, A.2    Prickaerts, J.3
  • 14
    • 0037468419 scopus 로고    scopus 로고
    • Synthesis and dopamine receptor modulating activity of 3-substituted gamma-lactam peptidomimetics of l-prolyl-l-leucyl-glycinamide
    • Dolbeare K., Pontoriero G.F., Gupta S.K., Mishra R.K., and Johnson R.L. Synthesis and dopamine receptor modulating activity of 3-substituted gamma-lactam peptidomimetics of l-prolyl-l-leucyl-glycinamide. J Med Chem 46 (2003) 727-733
    • (2003) J Med Chem , vol.46 , pp. 727-733
    • Dolbeare, K.1    Pontoriero, G.F.2    Gupta, S.K.3    Mishra, R.K.4    Johnson, R.L.5
  • 15
    • 0028141261 scopus 로고
    • Prevention and reversal of dopamine receptor supersensitivity by cyclo(leucyl-glycyl) (CLG): biphasic dose-response curves
    • Drucker G.E., Ritzmann R.F., Wichlinski L.J., Engh K., Gordon J.H., and Fields J.Z. Prevention and reversal of dopamine receptor supersensitivity by cyclo(leucyl-glycyl) (CLG): biphasic dose-response curves. Pharmacol Biochem Behav 47 (1994) 141-145
    • (1994) Pharmacol Biochem Behav , vol.47 , pp. 141-145
    • Drucker, G.E.1    Ritzmann, R.F.2    Wichlinski, L.J.3    Engh, K.4    Gordon, J.H.5    Fields, J.Z.6
  • 16
    • 0030712881 scopus 로고    scopus 로고
    • Treatment of tardive dyskinesia
    • Egan M.F., Apud J., and Wyatt R.J. Treatment of tardive dyskinesia. Schizophr Bull 23 (1997) 583-609
    • (1997) Schizophr Bull , vol.23 , pp. 583-609
    • Egan, M.F.1    Apud, J.2    Wyatt, R.J.3
  • 17
    • 0016260920 scopus 로고
    • Letter: lithium and M.R.I.H. in tardive dyskinesia
    • Ehrensing R.H. Letter: lithium and M.R.I.H. in tardive dyskinesia. Lancet 2 (1974) 1459-1460
    • (1974) Lancet , vol.2 , pp. 1459-1460
    • Ehrensing, R.H.1
  • 18
    • 0015996803 scopus 로고
    • Melanocyte-stimulating hormone-release inhibiting hormone as a antidepressant. A pilot study
    • Ehrensing R.H., and Kastin A.J. Melanocyte-stimulating hormone-release inhibiting hormone as a antidepressant. A pilot study. Arch Gen Psychiatry 30 (1974) 63-65
    • (1974) Arch Gen Psychiatry , vol.30 , pp. 63-65
    • Ehrensing, R.H.1    Kastin, A.J.2
  • 19
    • 0017347555 scopus 로고
    • Melanocyte-stimulating-hormone release-inhibiting factor-I and tardive dyskinesia
    • Ehrensing R.H., Kastin A.J., Larsons P.F., and Bishop G.A. Melanocyte-stimulating-hormone release-inhibiting factor-I and tardive dyskinesia. Dis Nerv Syst 38 (1977) 303-307
    • (1977) Dis Nerv Syst , vol.38 , pp. 303-307
    • Ehrensing, R.H.1    Kastin, A.J.2    Larsons, P.F.3    Bishop, G.A.4
  • 21
    • 0033594361 scopus 로고    scopus 로고
    • Synthesis and dopamine receptor modulating activity of novel peptidomimetics of l-prolyl-l-leucyl-glycinamide featuring alpha,alpha-disubstituted amino acids
    • Evans M.C., Pradhan A., Venkatraman S., Ojala W.H., Gleason W.B., Mishra R.K., et al. Synthesis and dopamine receptor modulating activity of novel peptidomimetics of l-prolyl-l-leucyl-glycinamide featuring alpha,alpha-disubstituted amino acids. J Med Chem 42 (1999) 1441-1447
    • (1999) J Med Chem , vol.42 , pp. 1441-1447
    • Evans, M.C.1    Pradhan, A.2    Venkatraman, S.3    Ojala, W.H.4    Gleason, W.B.5    Mishra, R.K.6
  • 22
    • 0020044368 scopus 로고
    • Oral dyskinesia in rats following brain lesions and neuroleptic drug administration
    • Gunne L.M., Growdon J., and Glaeser B. Oral dyskinesia in rats following brain lesions and neuroleptic drug administration. Psychopharmacology (Berl) 77 (1982) 134-139
    • (1982) Psychopharmacology (Berl) , vol.77 , pp. 134-139
    • Gunne, L.M.1    Growdon, J.2    Glaeser, B.3
  • 23
    • 0022534215 scopus 로고
    • Acute administration of MIF-1 or Tyr-MIF-1 inhibits haloperidol-induced catalepsy in rats
    • Hara C., and Kastin A.J. Acute administration of MIF-1 or Tyr-MIF-1 inhibits haloperidol-induced catalepsy in rats. Pharmacol Biochem Behav 24 (1986) 1785-1787
    • (1986) Pharmacol Biochem Behav , vol.24 , pp. 1785-1787
    • Hara, C.1    Kastin, A.J.2
  • 24
    • 0022967724 scopus 로고
    • Biphasic effects of MIF-1 and Tyr-MIF-1 on apomorphine-induced stereotypy in rats
    • Hara C., and Kastin A.J. Biphasic effects of MIF-1 and Tyr-MIF-1 on apomorphine-induced stereotypy in rats. Pharmacol Biochem Behav 25 (1986) 757-761
    • (1986) Pharmacol Biochem Behav , vol.25 , pp. 757-761
    • Hara, C.1    Kastin, A.J.2
  • 25
    • 0031981787 scopus 로고    scopus 로고
    • Mixture in the distribution of haloperidol-induced oral dyskinesias in the rat supports an animal model of tardive dyskinesia
    • Hashimoto T., Ross D.E., Gao X.M., Medoff D.R., and Tamminga C.A. Mixture in the distribution of haloperidol-induced oral dyskinesias in the rat supports an animal model of tardive dyskinesia. Psychopharmacology (Berl) 137 (1998) 107-112
    • (1998) Psychopharmacology (Berl) , vol.137 , pp. 107-112
    • Hashimoto, T.1    Ross, D.E.2    Gao, X.M.3    Medoff, D.R.4    Tamminga, C.A.5
  • 26
    • 0027449341 scopus 로고
    • Correlation of apomorphine- and amphetamine-induced turning with nigrostriatal dopamine content in unilateral 6-hydroxydopamine lesioned rats
    • Hudson J.L., van Horne C.G., Stromberg I., Brock S., Clayton J., Masserano J., et al. Correlation of apomorphine- and amphetamine-induced turning with nigrostriatal dopamine content in unilateral 6-hydroxydopamine lesioned rats. Brain Res 626 (1993) 167-174
    • (1993) Brain Res , vol.626 , pp. 167-174
    • Hudson, J.L.1    van Horne, C.G.2    Stromberg, I.3    Brock, S.4    Clayton, J.5    Masserano, J.6
  • 27
    • 0033452716 scopus 로고    scopus 로고
    • Effects of chronic haloperidol and clozapine on vacuous chewing and dopamine-mediated jaw movements in rats: evaluation of a revised animal model of tardive dyskinesia
    • Ikeda H., Adachi K., Hasegawa M., Sato M., Hirose N., Koshikawa N., et al. Effects of chronic haloperidol and clozapine on vacuous chewing and dopamine-mediated jaw movements in rats: evaluation of a revised animal model of tardive dyskinesia. J Neural Transm 106 (1999) 1205-1216
    • (1999) J Neural Transm , vol.106 , pp. 1205-1216
    • Ikeda, H.1    Adachi, K.2    Hasegawa, M.3    Sato, M.4    Hirose, N.5    Koshikawa, N.6
  • 28
    • 0022874763 scopus 로고
    • 2 analogues possessing cyclic amino acid residues at the C-terminal position
    • 2 analogues possessing cyclic amino acid residues at the C-terminal position. J Med Chem 29 (1986) 2100-2104
    • (1986) J Med Chem , vol.29 , pp. 2100-2104
    • Johnson, R.L.1    Rajakumar, G.2    Mishra, R.K.3
  • 29
    • 0022472378 scopus 로고
    • 2 analogues modified at the prolyl residue and evaluation of their effects on the receptor binding activity of the central dopamine receptor agonist, ADTN
    • 2 analogues modified at the prolyl residue and evaluation of their effects on the receptor binding activity of the central dopamine receptor agonist, ADTN. J Med Chem 29 (1986) 2104-2107
    • (1986) J Med Chem , vol.29 , pp. 2104-2107
    • Johnson, R.L.1    Rajakumar, G.2    Yu, K.L.3    Mishra, R.K.4
  • 30
    • 0015499661 scopus 로고
    • Preliminary clinical studies with l-prolyl-l-leucyl-glycine amide in Parkinson's disease
    • Kastin A.J., and Barbeau A. Preliminary clinical studies with l-prolyl-l-leucyl-glycine amide in Parkinson's disease. Can Med Assoc J 107 (1972) 1079-1081
    • (1972) Can Med Assoc J , vol.107 , pp. 1079-1081
    • Kastin, A.J.1    Barbeau, A.2
  • 31
    • 0018168469 scopus 로고
    • Potentiation of apomorphine action in rats by l-prolyl-l-leucyl-glycine amide
    • Kostrzewa R.M., Kastin A.J., and Sobrian S.K. Potentiation of apomorphine action in rats by l-prolyl-l-leucyl-glycine amide. Pharmacol Biochem Behav 9 (1978) 375-378
    • (1978) Pharmacol Biochem Behav , vol.9 , pp. 375-378
    • Kostrzewa, R.M.1    Kastin, A.J.2    Sobrian, S.K.3
  • 36
    • 0023543618 scopus 로고
    • Pharmacological activities of the MIF-1 analogues Pro-Leu-Gly, Tyr-Pro-Leu-Gly and peptide
    • Mycroft F.J., Bhargava H.N., and Wei E.T. Pharmacological activities of the MIF-1 analogues Pro-Leu-Gly, Tyr-Pro-Leu-Gly and peptide. Peptides 8 (1987) 1051-1055
    • (1987) Peptides , vol.8 , pp. 1051-1055
    • Mycroft, F.J.1    Bhargava, H.N.2    Wei, E.T.3
  • 37
    • 0030597196 scopus 로고    scopus 로고
    • Modulation of dopaminergic neurotransmission in the 6-hydroxydopamine lesioned rotational model by peptidomimetic analogues of l-prolyl-l-leucyl-glycinamide
    • Ott M.C., Mishra R.K., and Johnson R.L. Modulation of dopaminergic neurotransmission in the 6-hydroxydopamine lesioned rotational model by peptidomimetic analogues of l-prolyl-l-leucyl-glycinamide. Brain Res 737 (1996) 287-291
    • (1996) Brain Res , vol.737 , pp. 287-291
    • Ott, M.C.1    Mishra, R.K.2    Johnson, R.L.3
  • 38
    • 0023402612 scopus 로고
    • Down-regulation of haloperidol-induced striatal dopamine receptor supersensitivity by active analogues of l-prolyl-l-leucyl-glycinamide (PLG)
    • Rajakumar G., Naas F., Johnson R.L., Chiu S., Yu K.L., and Mishra R.K. Down-regulation of haloperidol-induced striatal dopamine receptor supersensitivity by active analogues of l-prolyl-l-leucyl-glycinamide (PLG). Peptides 8 (1987) 855-861
    • (1987) Peptides , vol.8 , pp. 855-861
    • Rajakumar, G.1    Naas, F.2    Johnson, R.L.3    Chiu, S.4    Yu, K.L.5    Mishra, R.K.6
  • 40
    • 7244247021 scopus 로고    scopus 로고
    • Electron spin resonance spectroscopy reveals alpha-phenyl-N-tert-butylnitrone spin-traps free radicals in rat striatum and prevents haloperidol-induced vacuous chewing movements in the rat model of human tardive dyskinesia
    • Rogoza R.M., Fairfax D.F., Henry P., Marandi S., Khan R.F., Gupta S.K., et al. Electron spin resonance spectroscopy reveals alpha-phenyl-N-tert-butylnitrone spin-traps free radicals in rat striatum and prevents haloperidol-induced vacuous chewing movements in the rat model of human tardive dyskinesia. Synapse 54 (2004) 156
    • (2004) Synapse , vol.54 , pp. 156
    • Rogoza, R.M.1    Fairfax, D.F.2    Henry, P.3    Marandi, S.4    Khan, R.F.5    Gupta, S.K.6
  • 41
    • 0034087775 scopus 로고    scopus 로고
    • The current status of tardive dyskinesia
    • Sachdev P.S. The current status of tardive dyskinesia. Aust N Z J Psychiatry 34 (2000) 355-369
    • (2000) Aust N Z J Psychiatry , vol.34 , pp. 355-369
    • Sachdev, P.S.1
  • 43
    • 25444442033 scopus 로고    scopus 로고
    • Novel oral drug administration in an animal model of neuroleptic therapy
    • Schleimer S.B., Johnston G.A., and Henderson J.M. Novel oral drug administration in an animal model of neuroleptic therapy. J Neurosci Methods 146 (2005) 159-164
    • (2005) J Neurosci Methods , vol.146 , pp. 159-164
    • Schleimer, S.B.1    Johnston, G.A.2    Henderson, J.M.3
  • 45
    • 0037303584 scopus 로고    scopus 로고
    • Pro-Leu-glycinamide and its peptidomimetic, PAOPA, attenuate haloperidol induced vacuous chewing movements in rat: a model of human tardive dyskinesia
    • Sharma S., Paladino P., Gabriele J., Saeedi H., Henry P., Chang M., et al. Pro-Leu-glycinamide and its peptidomimetic, PAOPA, attenuate haloperidol induced vacuous chewing movements in rat: a model of human tardive dyskinesia. Peptides 24 (2003) 313-319
    • (2003) Peptides , vol.24 , pp. 313-319
    • Sharma, S.1    Paladino, P.2    Gabriele, J.3    Saeedi, H.4    Henry, P.5    Chang, M.6
  • 46
    • 0020075357 scopus 로고
    • The effects of prolyl-leucyl-glycine amide on drug-induced rotation in lesioned rats
    • Smith J.R., and Morgan M. The effects of prolyl-leucyl-glycine amide on drug-induced rotation in lesioned rats. Gen Pharmacol 13 (1982) 203-207
    • (1982) Gen Pharmacol , vol.13 , pp. 203-207
    • Smith, J.R.1    Morgan, M.2
  • 47
    • 0023870799 scopus 로고
    • 2 receptor: evidence for modulation of agonist affinity states in bovine striatal membranes
    • 2 receptor: evidence for modulation of agonist affinity states in bovine striatal membranes. J Neurochem 50 (1988) 960-968
    • (1988) J Neurochem , vol.50 , pp. 960-968
    • Srivastava, L.K.1    Bajwa, S.B.2    Johnson, R.L.3    Mishra, R.K.4
  • 49
    • 13444283624 scopus 로고    scopus 로고
    • Continuous but not intermittent olanzapine infusion induces vacuous chewing movements in rats
    • Turrone P., Remington G., Kapur S., and Nobrega J.N. Continuous but not intermittent olanzapine infusion induces vacuous chewing movements in rats. Biol Psychiatry 57 (2005) 406-411
    • (2005) Biol Psychiatry , vol.57 , pp. 406-411
    • Turrone, P.1    Remington, G.2    Kapur, S.3    Nobrega, J.N.4
  • 50
    • 0036106055 scopus 로고    scopus 로고
    • The vacuous chewing movement (VCM) model of tardive dyskinesia revisited: is there a relationship to dopamine D(2) receptor occupancy?
    • Turrone P., Remington G., and Nobrega J.N. The vacuous chewing movement (VCM) model of tardive dyskinesia revisited: is there a relationship to dopamine D(2) receptor occupancy?. Neurosci Biobehav Rev 26 (2002) 361-380
    • (2002) Neurosci Biobehav Rev , vol.26 , pp. 361-380
    • Turrone, P.1    Remington, G.2    Nobrega, J.N.3
  • 51
    • 27744575172 scopus 로고    scopus 로고
    • Modulation of agonist binding to human dopamine receptor subtypes by l-prolyl-l-leucyl-glycinamide and a peptidomimetic analog
    • Verma V., Mann A., Costain W., Pontoriero G., Castellano J.M., Skoblenick K., et al. Modulation of agonist binding to human dopamine receptor subtypes by l-prolyl-l-leucyl-glycinamide and a peptidomimetic analog. J Pharmacol Exp Ther 315 (2005) 1228-1236
    • (2005) J Pharmacol Exp Ther , vol.315 , pp. 1228-1236
    • Verma, V.1    Mann, A.2    Costain, W.3    Pontoriero, G.4    Castellano, J.M.5    Skoblenick, K.6
  • 52
    • 0036159250 scopus 로고    scopus 로고
    • Clozapine, olanzapine, risperidone, and haloperidol in the treatment of patients with chronic schizophrenia and schizoaffective disorder
    • Volavka J., Czobor P., Sheitman B., Lindenmayer J.P., Citrome L., McEvoy J.P., et al. Clozapine, olanzapine, risperidone, and haloperidol in the treatment of patients with chronic schizophrenia and schizoaffective disorder. Am J Psychiatry 159 (2002) 255-262
    • (2002) Am J Psychiatry , vol.159 , pp. 255-262
    • Volavka, J.1    Czobor, P.2    Sheitman, B.3    Lindenmayer, J.P.4    Citrome, L.5    McEvoy, J.P.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.